Cannabinoid Receptor Modulators for Cancer Treatment Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cancer, particularly those involving cannabinoids, face challenges in effectively targeting specific types of cancer such as prostate cancer, leukemia, lymphoma, and CNS tumors, due to the limited specificity and efficacy of existing cannabinoid-based therapies.
Innovation Solution
A composition comprising a compound of Formula Ia or its pharmaceutically acceptable salt, solvate, hydrate, and/or N-oxide, combined with known pharmaceutical agents like inhibitors of multidrug resistance, anti-emetic agents, agents for treating anemia, neutropenia, immunologic-enhancing agents, and anticancer agents, is administered to treat cancer types excluding prostate cancer, leukemia, lymphoma, and CNS tumors, leveraging the compound's therapeutic effects to enhance treatment outcomes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing cannabinoid-based therapies are used to treat cancer, then some therapeutic effect is achieved, but the treatment lacks specificity for certain cancer types (prostate cancer, leukemia, lymphoma, and CNS tumors)
Solution Approach 1:
The patent modifies the cannabinoid compound structure by introducing specific substituents at defined positions (R1-R9) to create variants with differentiated properties. This structural differentiation enables specific cancer types to be targeted by specific compound variants, resolving the contradiction between maintaining therapeutic efficacy and achieving cancer type specificity.
Solution Approach 2:
The patent systematically varies chemical parameters of the cannabinoid compounds (substituent types, positions, and configurations) to modulate their biological activity profiles. By changing these molecular parameters, the compounds can be optimized for specific cancer types while maintaining their core therapeutic mechanism, thus achieving both reliability and adaptability.
2Adaptability or versatility
If cannabinoid compounds are used to treat cancer, then therapeutic effects are achieved, but the treatment options are limited for certain cancer types
Solution Approach 1:
The patent creates a family of cannabinoid compounds with a core structure that maintains universal anti-cancer activity, while allowing specific substituents to tailor the treatment for different cancer types. This multi-functional approach enables a single compound family to address multiple cancer indications, expanding treatment coverage without proportionally increasing complexity.
Solution Approach 2:
The patent divides the cannabinoid compound structure into a core scaffold and variable substituent regions. This segmentation allows the core structure to provide universal therapeutic activity while the substituents can be independently optimized for specific cancer types, managing complexity through modular design.
Data Source
AI summary
Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;